Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC6A4 | P31645 | 1/20 | 0.64 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.64 |
| ▸ | NR4A1 | P22736 | 1/20 | 0.56 |
| ▸ | BRS3 | P32247 | 1/20 | 0.54 |
| ▸ | LTB4R2 | Q9NPC1 | 3/20 | 0.53 |
| ▸ | HNF4A | P41235 | 1/20 | 0.53 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.53 |
| ▸ | RAB9A | P51151 | 2/20 | 0.53 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.52 |
| ▸ | BCAT2 | O15382 | 1/20 | 0.52 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.50 |
| ▸ | FTO | Q9C0B1 | 1/20 | 0.50 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.50 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.50 |
| ▸ | GAA | P10253 | 1/20 | 0.50 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.50 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.50 |
| ▸ | CTRC | Q99895 | 1/20 | 0.49 |
| ▸ | FABP3 | P05413 | 1/20 | 0.49 |
| ▸ | FABP4 | P15090 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30292805 | 0.89 | HNF4A (0.63) | LTB4R2HNF4AKDM4ERAB9AALDH1A1 | |
| SCHEMBL18759613 | 0.89 | HNF4A (0.63) | LTB4R2HNF4AKDM4ERAB9AALDH1A1 | |
| SCHEMBL11554621 | 0.87 | HNF4A (0.61) | SLC6A3LTB4R2HNF4ARAB9AALDH1A1 | |
| SCHEMBL10631889 | 0.86 | SLC6A4 (0.66) | SLC6A4SLC6A3NR4A1BRS3BCAT2 | |
| SCHEMBL505412 | 0.85 | HNF4A (0.64) | BRS3LTB4R2HNF4ARAB9AALDH1A1 | |
| SCHEMBL32677769 | 0.85 | HNF4A (0.64) | BRS3LTB4R2HNF4ARAB9AALDH1A1 | |
| SCHEMBL32677772 | 0.85 | HNF4A (0.64) | BRS3LTB4R2HNF4ARAB9AALDH1A1 | |
| SCHEMBL133057 | 0.85 | HNF4A (0.69) | LTB4R2HNF4AKDM4ERAB9AALDH1A1 | |
| Benzene SCHEMBL1403559 | 0.85 | HNF4A (0.69) | LTB4R2HNF4AKDM4ERAB9AALDH1A1 | |
| Benzene SCHEMBL28480917 | 0.85 | HNF4A (0.69) | LTB4R2HNF4AKDM4ERAB9AALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 58 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-120025244-A | Synthesis method of 2- (4' -chlorophenyl) benzoic acid | 浙江工业大学 | 2025-05-23 | — | — | CN | claimed |
| CN-109232411-B | Method for preparing boscalid | 广东广康生化科技股份有限公司 | 2021-10-01 | — | — | CN | claimed |
| CN-111662184-A | Synthetic method of boscalid intermediate 2- (4' -chlorphenyl) aniline | 广东广康生化科技股份有限公司 | 2020-09-15 | — | — | CN | claimed |
| CN-109232411-A | A method of preparing boscalid | 广东广康生化科技股份有限公司 | 2019-01-18 | — | — | CN | claimed |
| US-12398120-B2 | Substituted hydantoinamides as ADAMTS7 antagonists | BAYER AKTIENGESELLSCHAFT (DE) | 2025-08-26 | — | — | US | disclosed |
| CN-120025244-A | Synthesis method of 2- (4' -chlorophenyl) benzoic acid | 浙江工业大学 | 2025-05-23 | — | — | CN | disclosed |
| CN-120025244-A | Synthesis method of 2- (4' -chlorophenyl) benzoic acid | 浙江工业大学 | 2025-05-23 | — | — | CN | disclosed |
| CN-120025244-A | Synthesis method of 2- (4' -chlorophenyl) benzoic acid | 浙江工业大学 | 2025-05-23 | — | — | CN | disclosed |
| EP-4058448-B1 | HYDANTOIN DERIVATIVES AS ADAMTS7 ANTAGONISTS FOR THE TREATMENT OF CARDIOVASCULAR DISEASES | BAYER AG (DE) | 2024-05-29 | — | — | EP | disclosed |
| CN-115286514-B | Preparation method of 4' -chloro-2-aminobiphenyl sulfate | 山东京博农化科技股份有限公司 | 2024-01-12 | — | — | CN | disclosed |
| US-20230027346-A1 | SUBSTITUTED HYDANTOINAMIDES AS ADAMTS7 ANTAGONISTS | BAYER AKTIENGESELLSCHAFT (DE) | 2023-01-26 | — | — | US | disclosed |
| CN-115286514-A | Preparation method of 4' -chloro-2-aminobiphenyl sulfate | 京博农化科技有限公司 | 2022-11-04 | — | — | CN | disclosed |
| EP-1283055-A1 | SOLUBLE BETA AMYLOID PRECURSOR PROTEIN SECRETION PROMOTERS | Takeda Chemical Industries, Ltd. (JP) | 2003-02-12 | — | — | EP | disclosed |
| WO-2002028835-A1 | BENZAMIDE COMPOUNDS AS APO B SECRETION INHIBITORS | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 2002-04-11 | — | — | WO | disclosed |
| EP-1138712-A2 | Polyarylene copolymers and proton-conductive membrane | JSR Corporation (JP) | 2001-10-04 | — | — | EP | disclosed |
| US-5580741-A | INCUBATING SAMPLE SOLUTION IN CONTAINER PRECOATED WITH ANTIBODY AND PROTEIN CONJUGATE YIELDS COMPLEXES, THEN REMOVAL AND REACTION WITH CHEMILUMINESCENT REAGENTS FOR MEASUREMENT OF LIGHT INTENSITY, FOR CHLORINATED BIPHENYLS | GENERAL ELECTRIC COMPANY (US) | 1996-12-03 | — | — | US | disclosed |
| US-5466858-A | Ruthenium catalyst, high selectivity with a carboxylic acid | UBE INDUSTRIES, LTD. (JP) | 1995-11-14 | — | — | US | disclosed |
| EP-0059983-B1 | SUBSTITUTED BIPHENYL COMPOUNDS FOR USE AS A MEDICAMENT | THE WELLCOME FOUNDATION LIMITED (GB) | 1986-06-11 | — | — | EP | disclosed |
| US-4578522-A | CHEMICAL INTERMEDIATES FOR BLOOD LIPID CONTROLLING COMPOUNDS | BURROUGHS WELLCOME CO. | 1986-03-25 | — | — | US | disclosed |
| EP-0059983-A1 | Substituted biphenyl compounds for use as a medicament | THE WELLCOME FOUNDATION LIMITED (GB) | 1982-09-15 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12398120-B2 | Substituted hydantoinamides as ADAMTS7 antagonists | ADAMTS7, MMP7, ADAM17 | SLC6A4 1821/4885SLC6A3 1469/4885NR4A1 2906/4885 |
| US-20230027346-A1 | SUBSTITUTED HYDANTOINAMIDES AS ADAMTS7 ANTAGONISTS | ADAMTS7, MMP7, ADAM17 | SLC6A4 1821/4885SLC6A3 1469/4885NR4A1 2906/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.